Showing results (231-240 of 413) with videos related to

Sort By:
Pageof 42
The American Journal of Pathology|April 12, 2002
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutationsSusan C Abraham, David S Klimstra, Robb E Wilentz, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 16, 2011
High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomyKai A Bickenbach, Jinru Shia, David S Klimstra, et al.
Cancer Cytopathology|October 19, 2017
Assessment of cytologic differentiation in high-grade pancreatic neuroendocrine neoplasms: A multi-institutional studyCarlie S Sigel, Vitor Werneck Krauss Silva, Michelle D Reid, et al.
AJR. American Journal of Roentgenology|October 24, 2014
Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCTRichard K G Do, Seth S Katz, Marc J Gollub, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2003
Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesionsAnil V Parwani, Joseph Geradts, Eric Caspers, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 17, 2003
Impact of steatosis on perioperative outcome following hepatic resectionDavid A Kooby, Yuman Fong, Arief Suriawinata, et al.
Annals of Surgical Oncology|July 16, 2011
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decadesJordan M Winter, Murray F Brennan, Laura H Tang, et al.
Cancer Cytopathology|February 17, 2018
Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic studyCarlie S Sigel, Vitor Werneck Krauss Silva, Michelle D Reid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 28, 2018
Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumorsAlessandra Pulvirenti, Deepthi Rao, Caitlin A Mcintyre, et al.
Pageof 42